Polycystic ovary syndrome (PCOS) is the most common hormonal disorder in women of reproductive age, affecting approximately 8-13% of women — about 1 in 10. Despite its name suggesting a primary ovarian problem, PCOS is a complex metabolic and hormonal condition characterized by irregular periods, elevated male hormones (androgens), and insulin resistance. Named in the 1930s when ovarian cysts were considered the defining feature, we now understand PCOS extends far beyond the reproductive system.

PCOS typically manifests during adolescence or early adulthood with irregular periods, acne, or weight gain — symptoms often dismissed as “normal teenage issues.” However, PCOS doesn’t resolve on its own. Alarmingly, up to 70% of women with PCOS remain undiagnosed, often suffering for years with unexplained symptoms, irregular periods dismissed as “normal,” or fertility challenges attributed to other causes. Without recognition and management, the condition progresses, causing worsening insulin resistance, difficult-to-reverse weight gain, infertility when pregnancy is desired, and dramatically elevated risk for type 2 diabetes (50% lifetime risk), cardiovascular disease, metabolic syndrome, and endometrial cancer.

The core pathophysiology centers on insulin resistance and hormonal dysregulation. Elevated insulin levels stimulate ovaries to produce excess testosterone and other androgens. These elevated androgens disrupt normal ovulation, causing irregular or absent periods and infertility, while also causing acne, excess facial and body hair (hirsutism), and male-pattern hair loss. Meanwhile, insulin resistance drives weight gain (particularly abdominal fat), worsens hormonal imbalances creating a vicious cycle, and dramatically increases diabetes risk.

This understanding of PCOS as fundamentally a metabolic disorder — not just a reproductive problem — has transformed management approaches, emphasizing lifestyle interventions and insulin-sensitizing medications alongside hormonal treatments. Early diagnosis is crucial. PCOS diagnosed and managed in younger women responds better to lifestyle interventions, fertility outcomes improve, and long-term metabolic complications can be prevented or delayed. With appropriate treatment — lifestyle modifications, medications targeted to specific symptoms, and regular monitoring for complications—most women with PCOS live healthy, fulfilling lives, achieve pregnancy when desired, and prevent or minimize long-term health consequences.

Quick Summary:

• PCOS affects 8-13% of women of reproductive age—about 1 in 10 women—making it the most common hormonal disorder
• Up to 70% of women with PCOS are undiagnosed, often suffering years with irregular periods, weight gain, and fertility problems
• PCOS is diagnosed using Rotterdam criteria: need 2 of 3 features—irregular ovulation, elevated androgens, polycystic ovaries on ultrasound
• Insulin resistance is central to PCOS—70-80% of women with PCOS have insulin resistance regardless of weight
• Classic symptoms include irregular or absent periods, acne, excess facial/body hair (hirsutism), male-pattern hair loss, weight gain, and infertility
• PCOS dramatically increases long-term health risks: 50% lifetime diabetes risk, 3-7x higher cardiovascular disease risk, metabolic syndrome, endometrial cancer risk
• Blood tests for diagnosis include total testosterone, free testosterone, DHEA-S, LH/FSH ratio, fasting insulin, glucose, lipid panel
• Lifestyle modification is first-line treatment—even 5-10% weight loss significantly improves symptoms, insulin resistance, and fertility
• Medications target specific problems: metformin for insulin resistance, hormonal contraceptives for cycle regulation, spironolactone for hirsutism
• Fertility treatment is highly effective with ovulation-inducing medications (clomiphene, letrozole) achieving pregnancy in most women with PCOS
• PCOS is chronic but manageable—proper treatment controls symptoms, restores fertility, and prevents long-term complications
• Early diagnosis and intervention are crucial for best outcomes and preventing metabolic disease progression

---

What Is Polycystic Ovary Syndrome (PCOS)?

Polycystic ovary syndrome is a hormonal and metabolic disorder affecting women during their reproductive years (typically ages 15-44, though effects persist throughout life). Despite the name suggesting a primary ovarian problem, PCOS is a systemic condition involving the ovaries, pituitary gland, adrenal glands, pancreas (insulin regulation), and fat tissue—all interacting in complex ways to produce the syndrome’s varied manifestations.

The Three Core Features

PCOS is defined by the presence of at least two of three core features (Rotterdam criteria, the most widely used diagnostic criteria):

1. Ovulatory Dysfunction (Irregular or Absent Ovulation):

Normal menstrual cycles occur every 21-35 days, representing regular monthly ovulation. In PCOS, hormonal imbalances disrupt the normal ovulatory cycle, causing irregular periods (cycles longer than 35 days or fewer than 8 periods yearly), absent periods (amenorrhea), or unpredictable bleeding. This ovulatory dysfunction is the primary cause of infertility in PCOS—without regular ovulation, pregnancy cannot occur naturally.

2. Hyperandrogenism (Elevated Male Hormones):

Women normally produce small amounts of androgens (male hormones like testosterone). In PCOS, androgen production is excessive, either measured directly through blood tests (elevated testosterone, DHEA-S, androstenedione) or manifested clinically through:

• Hirsutism: Excess terminal (coarse, dark) hair growth in male-pattern distribution—face (particularly chin, upper lip, sideburns), chest, abdomen, back, inner thighs
• Acne: Persistent, often severe acne, particularly on face, chest, and back
• Androgenic alopecia: Male-pattern hair loss with thinning at crown and temples

3. Polycystic Ovarian Morphology:

On ultrasound, ovaries show 12 or more small follicles (2-9 mm diameter) arranged peripherally in one or both ovaries, giving a “string of pearls” appearance, and/or increased ovarian volume (>10 mL). These “cysts” aren’t true cysts but rather arrested follicle development—many eggs begin maturing each cycle but none completes maturation and ovulates, leaving multiple immature follicles visible on ultrasound.

Importantly, polycystic ovaries on ultrasound alone don’t diagnose PCOS (20-30% of women without PCOS have polycystic-appearing ovaries), nor are polycystic ovaries required for diagnosis if the other two features are present.

PCOS Phenotypes

Because PCOS requires only two of three features, different combinations create distinct presentations (“phenotypes”):

Phenotype A (Classic PCOS): All three features—irregular periods, high androgens, polycystic ovaries. This is the most common presentation with the worst metabolic profile.

Phenotype B (Non-PCO PCOS): Irregular periods and high androgens without polycystic ovaries on ultrasound. Similar metabolic risk to Phenotype A.

Phenotype C (Ovulatory PCOS): High androgens and polycystic ovaries but regular ovulation/periods. Less common, generally better metabolic profile.

Phenotype D (Mild PCOS): Irregular periods and polycystic ovaries without obvious hyperandrogenism. Most common in adolescents, may have milder metabolic effects but still significant long-term risks.

These phenotypes emphasize PCOS heterogeneity—not all women with PCOS present identically, though most share core metabolic disturbances regardless of phenotype.

The Role of Insulin Resistance

Insulin resistance is central to PCOS pathophysiology and present in 70-80% of women with PCOS, including 30-40% of lean women with PCOS (dispelling the myth that PCOS only affects overweight women). Insulin resistance means cells don’t respond normally to insulin, requiring higher insulin levels to maintain normal blood glucose. This compensatory hyperinsulinemia (elevated insulin levels) drives much of PCOS pathology:

Hyperinsulinemia stimulates ovarian androgen production: Insulin directly stimulates ovarian theca cells to produce testosterone, independent of luteinizing hormone (LH).

Hyperinsulinemia reduces SHBG: Insulin suppresses liver production of sex hormone-binding globulin (SHBG), the protein that binds testosterone in blood. Lower SHBG means more unbound (biologically active) testosterone, even if total testosterone is only mildly elevated.

Insulin and LH interact: Insulin amplifies LH’s effect on ovarian androgen production.

Insulin resistance promotes weight gain: Particularly abdominal fat accumulation, which worsens insulin resistance creating a vicious cycle.

This central role of insulin resistance explains why:

• Lifestyle interventions improving insulin sensitivity often restore ovulation and reduce androgens without directly targeting the ovaries
• Metformin, an insulin-sensitizing medication, improves multiple PCOS symptoms
• Weight loss (reducing insulin resistance) is often more effective than medications alone
• PCOS dramatically increases diabetes risk as insulin resistance progresses

---

How Common Is PCOS?

PCOS affects approximately 8-13% of women of reproductive age globally, with prevalence varying by diagnostic criteria used, population studied, and detection methods. This translates to about 1 in 10 women, or roughly 5 million American women, making PCOS:

• The most common endocrine disorder in women of reproductive age
• The leading cause of anovulatory infertility (infertility due to lack of ovulation)
• A major contributor to metabolic syndrome and diabetes in young women

Critically, up to 70% of women with PCOS remain undiagnosed. Many women live with symptoms for years—irregular periods dismissed as “normal,” acne attributed to other causes, weight gain blamed on diet alone—without receiving a PCOS diagnosis. The average delay from symptom onset to diagnosis is approximately 2-3 years, with many women diagnosed only when seeking fertility treatment.

Prevalence varies by ethnicity:

• South Asian and Middle Eastern women: Higher prevalence (up to 20%) and more severe metabolic complications
• Hispanic women: Higher prevalence in U.S. studies
• Asian women: More likely to be lean but still have significant insulin resistance
• African American women: Higher prevalence, more likely to have hirsutism
• White women: Lower prevalence in some studies but still common

PCOS prevalence may be increasing due to rising obesity rates (obesity worsens PCOS expression), better diagnostic awareness, improved ultrasound technology detecting polycystic ovaries, or actual increase in prevalence from environmental factors (endocrine disruptors, dietary changes).

---

Symptoms of PCOS

PCOS symptoms vary widely in type and severity. Some women have severe, obvious symptoms prompting early diagnosis, while others have subtle symptoms that go unrecognized for years. Importantly, you don’t need all symptoms to have PCOS—the syndrome is highly heterogeneous.

Menstrual Irregularities

The most common and often earliest symptom, affecting 70-80% of women with PCOS.

Oligomenorrhea (Infrequent Periods):

Menstrual cycles longer than 35 days or fewer than 8-9 periods per year. Cycles may be 40-60 days or even longer, unpredictable, making it difficult to plan life events or recognize pregnancy.

Amenorrhea (Absent Periods):

Complete absence of periods for 3+ months in women who previously menstruated. Some women with PCOS have only 2-4 periods yearly without intervention.

Irregular, Unpredictable Bleeding:

Periods that vary dramatically in timing, flow (sometimes very heavy, other times light spotting), and duration.

Adolescent Onset:

PCOS often manifests when menstruation begins. Girls whose periods never regulate after menarche (remaining irregular 2-3 years after first period) may have PCOS. Unfortunately, irregular periods in teens are often dismissed as “normal” when they may indicate PCOS requiring evaluation.

Hyperandrogenism Symptoms

Elevated androgens cause “masculine” features affecting approximately 70-80% of women with PCOS, though severity varies widely.

Hirsutism (Excess Hair Growth):

Coarse, dark terminal hair growth in male-pattern distribution:

• Face: Upper lip, chin, sideburns, full beard in severe cases
• Chest: Between breasts, around nipples
• Abdomen: From belly button downward (“treasure trail”)
• Back: Lower back, sometimes upper back
• Inner thighs and buttocks

Hirsutism severity is quantified using the Ferriman-Gallwey score (evaluating hair growth in 9 body areas). Mild hirsutism may involve only chin or upper lip hair requiring regular plucking. Severe hirsutism causes significant psychological distress and impacts quality of life. Importantly, hirsutism develops gradually over years—existing hair doesn’t disappear with treatment, though new growth can be prevented.

Acne:

Persistent, often severe acne affecting face (particularly jawline, chin), chest, and back. Acne in PCOS is typically “adult-onset” (continuing or starting after teenage years), resistant to conventional acne treatments, and characterized by deep, painful cysts rather than surface whiteheads. The distribution (lower face, jawline) and persistence into adulthood are clues suggesting hormonal causes like PCOS.

Androgenic Alopecia (Hair Loss):

Male-pattern hair loss with diffuse thinning at crown and temples, widening part, visible scalp. Unlike hirsutism (excess growth), this involves hair loss on the scalp where women typically have abundant hair. This is particularly distressing and often underrecognized as a PCOS symptom.

Oily Skin and Scalp:

Increased sebum production causing oily, acne-prone skin and greasy hair requiring frequent washing.

Weight and Body Composition Changes

Approximately 40-60% of women with PCOS are overweight or obese, though 30-40% are lean. The relationship between PCOS and weight is complex and bidirectional—PCOS promotes weight gain (through insulin resistance), and obesity worsens PCOS symptoms (further increasing insulin resistance).

Weight Gain:

Many women report gradual, progressive weight gain after PCOS onset, particularly if it coincides with starting birth control pills (which can mask PCOS while promoting weight gain). Weight gain is disproportionately abdominal (central/visceral adiposity), creating an “apple shape” rather than “pear shape,” which worsens insulin resistance and cardiovascular risk.

Difficulty Losing Weight:

Women with PCOS frequently report weight loss is extremely difficult despite diet and exercise efforts that would cause weight loss in other people. This reflects underlying insulin resistance impairing fat metabolism. However, weight loss is possible with appropriate interventions—it just requires more intensive efforts.

Weight Cycling:

Repeated cycles of losing and regaining weight, often with progressive net gain over time.

Importantly, 30-40% of women with PCOS are normal weight or lean. These women still have significant health risks, often have severe insulin resistance despite normal BMI, and may go undiagnosed longer because healthcare providers don’t “expect” PCOS in lean women.

Infertility and Pregnancy Complications

PCOS is the leading cause of anovulatory infertility, accounting for 70% of anovulation cases.

Difficulty Conceiving:

Women with irregular or absent ovulation rarely conceive naturally. Even women with PCOS who ovulate occasionally may have reduced fertility due to poor egg quality, unfavorable cervical mucus, and other factors.

Increased Miscarriage Risk:

Women with PCOS have 30-50% higher miscarriage rates, possibly related to insulin resistance, elevated androgens, or poor egg quality.

Pregnancy Complications:

PCOS significantly increases risks during pregnancy:

• Gestational diabetes: 2-3 times higher risk
• Preeclampsia: 2-3 times higher risk
• Preterm birth: Increased risk
• Larger babies: Increased macrosomia risk
• Cesarean delivery: Higher rates

Metabolic Symptoms

Many women with PCOS have no obvious metabolic symptoms initially, but metabolic dysfunction underlies much of PCOS pathology and drives long-term health risks.

Insulin Resistance Signs:

• Acanthosis nigricans: Dark, velvety skin discoloration in body folds (neck, armpits, groin, under breasts)—highly specific for insulin resistance
• Skin tags: Multiple small skin tags, particularly on neck
• Weight gain: Particularly abdominal
• Intense carbohydrate cravings

Prediabetes or Diabetes:

Up to 35% of women with PCOS have impaired glucose tolerance (prediabetes), and 10% have type 2 diabetes by age 40. Many are undiagnosed. Symptoms include increased thirst, frequent urination, fatigue, blurred vision.

Dyslipidemia:

Abnormal cholesterol—low HDL (“good” cholesterol), elevated triglycerides, sometimes elevated LDL. Often present even in young, lean women with PCOS.

Hypertension:

High blood pressure is more common in women with PCOS, even controlling for weight.

Psychological and Quality of Life Impact

PCOS significantly affects mental health and quality of life, often overlooked in clinical care.

Depression:

Women with PCOS have 3-4 times higher depression rates than women without PCOS. Contributing factors include hormonal imbalances, chronic disease burden, body image concerns, fertility challenges, and frustration with symptoms.

Anxiety:

Similarly elevated anxiety rates, including social anxiety related to physical appearance (hirsutism, acne, weight).

Eating Disorders:

Higher rates of disordered eating, binge eating disorder, and bulimia, possibly related to weight struggles, insulin resistance causing cravings, and psychological distress.

Body Image and Self-Esteem:

Hirsutism, acne, weight gain, and hair loss cause significant distress. Many women report spending hours daily managing hirsutism (plucking, shaving, bleaching), avoiding social situations, feeling “unfeminine,” and experiencing relationship difficulties.

Reduced Quality of Life:

Studies consistently show impaired quality of life in multiple domains—physical health, emotional wellbeing, social functioning, sexual satisfaction—comparable to or worse than chronic diseases like diabetes and asthma.

Long-Term Health Complications

PCOS has lifelong implications extending beyond reproductive years.

Type 2 Diabetes:

50% lifetime risk—approximately half of women with PCOS develop type 2 diabetes by age 40-50. This is 4-6 times higher than women without PCOS. Risk is present even in lean women with PCOS, though higher in overweight/obese women.

Cardiovascular Disease:

Women with PCOS have 3-7 times higher risk of coronary heart disease, stroke, and peripheral vascular disease compared to age-matched women without PCOS. Risk factors include insulin resistance, dyslipidemia, hypertension, obesity, and chronic inflammation.

Metabolic Syndrome:

A cluster of cardiovascular risk factors (abdominal obesity, elevated triglycerides, low HDL, high blood pressure, elevated fasting glucose) present in 30-40% of women with PCOS, even young women. Metabolic syndrome dramatically increases cardiovascular disease and diabetes risk.

Endometrial Cancer:

Women with chronic anovulation (no periods or very infrequent periods) have 2-6 times higher endometrial cancer risk due to unopposed estrogen exposure. Without regular periods, the endometrial lining builds up excessively without shedding, increasing cancer risk. This risk is preventable through inducing regular periods with hormonal contraceptives or progestin therapy.

Non-Alcoholic Fatty Liver Disease (NAFLD):

50-70% of women with PCOS have NAFLD (fat accumulation in liver), even those with normal weight. NAFLD can progress to cirrhosis if untreated.

Sleep Apnea:

5-10 times more common in women with PCOS, partly related to obesity but also independent of weight. Sleep apnea worsens insulin resistance and increases cardiovascular risk.

---

Causes and Pathophysiology of PCOS

PCOS has no single cause but rather results from complex interactions between genetic predisposition, hormonal dysregulation, metabolic disturbances, and environmental factors.

Genetic Factors

PCOS is highly heritable—if your mother or sister has PCOS, your risk increases 20-40%. Twin studies show 70-80% concordance in identical twins. However, no single “PCOS gene” exists. Rather, multiple genes affecting insulin action, hormone production, inflammation, and other pathways contribute small effects that accumulate to increase PCOS susceptibility.

Hormonal Dysregulation

LH and FSH Imbalance:

In PCOS, the pituitary gland produces disproportionate amounts of luteinizing hormone (LH) relative to follicle-stimulating hormone (FSH). Elevated LH-to-FSH ratio (often 2:1 or 3:1, though not present in all women with PCOS) stimulates ovarian theca cells to produce excess androgens while insufficient FSH prevents follicle maturation and ovulation.

Hyperandrogenism:

Ovaries produce excessive testosterone, androstenedione, and DHEA-S. This results from LH overstimulation, insulin’s direct effects on ovaries, and possibly genetic factors increasing androgen production capacity.

Insulin Resistance and Hyperinsulinemia:

As discussed, insulin resistance with compensatory hyperinsulinemia drives androgen overproduction, suppresses SHBG (increasing free androgens), promotes weight gain, and directly impairs ovarian function.

The Vicious Cycle

PCOS perpetuates itself through self-reinforcing cycles:

1. Insulin resistance → hyperinsulinemia → increased ovarian androgen production
2. Elevated androgens → anovulation → unopposed estrogen → worsening insulin resistance
3. Insulin resistance → weight gain (particularly visceral fat) → worsening insulin resistance
4. Anovulation → no progesterone production → continued LH elevation → more androgens

Breaking these cycles through lifestyle intervention or medication is key to management.

Fetal Programming

Some evidence suggests PCOS may originate in fetal development. Female fetuses exposed to excess androgens (from mother’s PCOS, certain medications, or other sources) may develop PCOS-like features in adulthood, suggesting “programming” of hormonal and metabolic systems before birth.

Environmental Factors

Endocrine Disruptors:

Chemicals that interfere with hormone systems—BPA (in plastics), phthalates (in cosmetics), pesticides—may contribute to PCOS development or worsen symptoms, though research is preliminary.

Diet and Lifestyle:

High-sugar, high-glycemic-index diets worsen insulin resistance. Sedentary lifestyle promotes weight gain and insulin resistance. These don’t cause PCOS in genetically non-susceptible individuals but likely trigger or worsen PCOS expression in susceptible women.

Obesity:

Obesity doesn’t cause PCOS (many lean women have PCOS), but obesity worsens every aspect—insulin resistance, androgen levels, anovulation, metabolic complications. Conversely, PCOS promotes obesity through insulin resistance, creating bidirectional causation.

---

Diagnosis of PCOS

PCOS diagnosis requires clinical evaluation, laboratory testing, and sometimes imaging, with careful exclusion of conditions that mimic PCOS.

Diagnostic Criteria

The most widely used diagnostic criteria are the Rotterdam criteria (2003), requiring 2 of 3 features:

1. Oligo-ovulation or anovulation (irregular or absent periods)
2. Clinical and/or biochemical signs of hyperandrogenism
3. Polycystic ovaries on ultrasound

Plus exclusion of other causes of irregular periods and hyperandrogenism (thyroid disorders, hyperprolactinemia, congenital adrenal hyperplasia, Cushing’s syndrome, androgen-secreting tumors).

Alternative criteria exist (NIH criteria require only hyperandrogenism plus ovulatory dysfunction; Androgen Excess Society criteria require hyperandrogenism plus one other feature) but Rotterdam criteria are most comprehensive and widely accepted.

Clinical Evaluation

Medical History:

• Menstrual pattern: Age at menarche, cycle regularity, frequency, predictability
• Symptoms: Hirsutism, acne, hair loss, weight changes, difficulty losing weight
• Fertility history: Time trying to conceive, previous pregnancies, miscarriages
• Family history: PCOS, diabetes, infertility in mother or sisters
• Medications: Current and past contraceptive use, other hormones
• Other health issues: Mood disorders, sleep problems

Physical Examination:

• BMI and waist circumference (assessing obesity and body fat distribution)
• Blood pressure
• Hirsutism assessment (Ferriman-Gallwey score)
• Acne evaluation
• Acanthosis nigricans (insulin resistance marker)
• Thyroid examination
• Signs of Cushing’s syndrome or other endocrine disorders

Laboratory Testing

A number of blood tests are associated with PCOS identification.

Androgens:

Total Testosterone: Typically mildly elevated (50-150 ng/dL) in PCOS. Levels >150-200 ng/dL suggest androgen-secreting tumor requiring further workup. Normal testosterone doesn’t exclude PCOS—some women have elevated free testosterone despite normal total testosterone due to low SHBG.

Free Testosterone: Often more sensitive than total testosterone. Can be directly measured or calculated from total testosterone and SHBG.

DHEA-S (Dehydroepiandrosterone Sulfate): Androgen produced by adrenal glands. Elevated in 20-30% of women with PCOS. Very high levels (>700 mcg/dL) suggest adrenal tumor.

Androstenedione: Another androgen, elevated in many women with PCOS.

SHBG (Sex Hormone-Binding Globulin): Typically low in PCOS due to insulin resistance. Low SHBG means more biologically active (free) testosterone.

Gonadotropins:

LH (Luteinizing Hormone) and FSH (Follicle-Stimulating Hormone): Classic finding is elevated LH-to-FSH ratio (≥2:1 or 3:1), though this is present in only 40-60% of women with PCOS and isn’t required for diagnosis. Checked in early follicular phase (days 2-5 of cycle) or random if not menstruating.

Metabolic Tests:

Fasting Glucose and Fasting Insulin: Assess insulin resistance. Fasting insulin >20 μIU/mL suggests insulin resistance. HOMA-IR (calculated from glucose and insulin) quantifies insulin resistance; >2.5 is considered elevated.

Oral Glucose Tolerance Test (OGTT): 75-gram glucose load with glucose measured at 0, 1, and 2 hours, plus insulin at same timepoints. This is the gold standard for detecting prediabetes and diabetes, both common in PCOS. OGTT should be performed at diagnosis in all women with PCOS and repeated every 2-3 years.

HbA1c: Reflects average blood glucose over 3 months. Should be checked annually to screen for diabetes.

Lipid Panel: Total cholesterol, LDL, HDL, triglycerides. Often abnormal in PCOS (low HDL, high triglycerides).

Other Tests:

TSH (Thyroid-Stimulating Hormone): Hypothyroidism causes similar symptoms (irregular periods, weight gain, fatigue) and must be excluded.

Prolactin: Elevated prolactin (hyperprolactinemia) causes irregular periods and infertility, mimicking PCOS. Prolactin should be checked in women with irregular periods.

17-Hydroxyprogesterone (17-OHP): Screens for non-classic congenital adrenal hyperplasia, which mimics PCOS. Levels >200 ng/dL require further testing (ACTH stimulation test).

Liver Function Tests: ALT, AST to screen for NAFLD.

Pelvic Ultrasound

Transvaginal or transabdominal ultrasound evaluates ovarian morphology. Polycystic ovaries are defined as:

• ≥12 follicles (2-9 mm diameter) in one or both ovaries, OR
• Ovarian volume >10 mL

Ultrasound should be performed in early follicular phase or random if amenorrheic. Ultrasound is not required for PCOS diagnosis if the other two Rotterdam criteria are met and is not recommended in adolescents (many adolescents have polycystic-appearing ovaries normally).

Exclusion of Other Conditions

Several conditions mimic PCOS and must be excluded:

• Hypothyroidism or hyperthyroidism (TSH)
• Hyperprolactinemia (prolactin)
• Non-classic congenital adrenal hyperplasia (17-OHP, ACTH stimulation test)
• Cushing’s syndrome (clinical features, 24-hour urine cortisol or dexamethasone suppression test)
• Androgen-secreting tumors (very high testosterone or DHEA-S levels, imaging)
• Premature ovarian insufficiency (FSH >25-30 in women under 40 with amenorrhea)

---

Treatment and Management of PCOS

PCOS has no cure but is highly manageable with lifestyle modifications, medications targeting specific symptoms, and regular monitoring. Treatment is individualized based on symptoms, priorities (fertility vs. symptom management), and metabolic status.

Lifestyle Modifications: First-Line Treatment

Lifestyle interventions are the foundation of PCOS management, often more effective than medications alone.

Weight Loss:

For overweight/obese women with PCOS, even 5-10% weight loss produces dramatic benefits:

• Restores regular menstruation in 50-70% of women
• Improves insulin sensitivity and reduces insulin levels
• Reduces androgen levels and improves hirsutism/acne
• Improves fertility—many women conceive naturally after modest weight loss
• Reduces cardiovascular risk factors
• Improves quality of life and mood

Weight loss in PCOS is challenging due to insulin resistance but achievable through:

• Caloric deficit (typically 500-750 calories/day reduction)
• Balanced macronutrients (avoiding very low-carb or very low-fat extremes)
• Regular meals preventing extreme hunger
• Addressing emotional eating
• Patience—weight loss may be slower than in women without PCOS

Diet:

No single “PCOS diet” is universally superior, but several principles help:

Low Glycemic Index (GI) Foods: Choosing complex carbohydrates that don’t spike blood sugar (whole grains, legumes, vegetables) over refined carbohydrates (white bread, white rice, sugary foods) improves insulin sensitivity and reduces insulin levels.

Balanced Meals: Including protein, healthy fats, and fiber with carbohydrates slows glucose absorption and reduces insulin spikes.

Mediterranean or DASH Diet: These anti-inflammatory diets improve metabolic markers in PCOS.

Adequate Protein: 1.2-1.5 g/kg body weight daily helps preserve muscle during weight loss and increases satiety.

Limiting Added Sugars: Particularly sugar-sweetened beverages, which cause large insulin spikes.

Some women benefit from moderate carbohydrate restriction (30-45% of calories from carbs rather than 50-60%), though very low-carb diets aren’t necessary and may be difficult to sustain.

Exercise:

Regular physical activity improves insulin sensitivity independent of weight loss:

• Aerobic exercise: 150 minutes/week moderate intensity (brisk walking, cycling, swimming)
• Resistance training: 2-3 sessions/week builds muscle, which improves metabolic health
• High-intensity interval training (HIIT): May be particularly effective for improving insulin sensitivity in shorter time

Exercise benefits occur even without weight loss, making it crucial for lean women with PCOS.

Sleep:

7-9 hours nightly. Sleep deprivation worsens insulin resistance and increases appetite. Many women with PCOS have sleep apnea requiring evaluation and treatment.

Stress Management:

Chronic stress elevates cortisol, worsening insulin resistance and promoting abdominal fat. Stress reduction techniques (mindfulness, yoga, counseling) may help metabolic and reproductive outcomes.

Medications for Metabolic Management

Metformin:

An insulin-sensitizing medication (typically used in type 2 diabetes) that improves insulin resistance, reduces insulin levels, and has multiple benefits in PCOS:

• Restores menstruation in 30-50% of women with irregular cycles
• Modestly reduces weight (typically 5-10 pounds) or prevents weight gain
• Reduces androgen levels
• May improve fertility (though less effective than ovulation-inducing drugs)
• Reduces progression to diabetes (50% risk reduction in women with prediabetes)
• Improves cardiovascular risk factors

Dose: Start 500 mg once daily with food, gradually increase over weeks to 1500-2000 mg daily (divided doses) to minimize gastrointestinal side effects (nausea, diarrhea, which usually resolve after 2-4 weeks). Extended-release formulation better tolerated.

Metformin is recommended for most women with PCOS, particularly those with impaired glucose tolerance, obesity, or metabolic syndrome, regardless of fertility desires.

Inositol:

Particularly myo-inositol, a supplement improving insulin signaling. Some studies show benefits similar to metformin for menstrual regularity and metabolic parameters. Typical dose: 2-4 grams daily. Generally well-tolerated with fewer gastrointestinal side effects than metformin.

GLP-1 Agonists:

Medications like liraglutide, semaglutide (typically used for diabetes and weight loss) show promise in PCOS for weight loss, improving insulin resistance, and potentially restoring ovulation. Not yet first-line but may be considered for women with obesity refractory to lifestyle and metformin.

Medications for Menstrual Regulation

Combined Oral Contraceptives (Birth Control Pills):

Hormonal contraceptives regulate menstrual cycles, reduce androgen levels, and improve hirsutism/acne:

• Provide regular, predictable periods (preventing endometrial hyperplasia)
• Suppress ovarian androgen production
• Increase SHBG (reducing free androgens)
• Reduce acne and hirsutism (improvement takes 3-6 months)

Most commonly used for women not actively trying to conceive. Concerns: May promote weight gain in some women, may slightly worsen insulin resistance (usually clinically insignificant), contraindicated with certain cardiovascular risk factors.

Anti-androgenic progestins (drospirenone, cyproterone acetate) in combination pills may provide additional hirsutism/acne benefits.

Progestin-Only Therapy:

For women who can’t take estrogen (obesity, blood clot risk, migraine with aura), cyclic progestin (medroxyprogesterone 10 mg for 10-14 days every 1-3 months) induces withdrawal bleeding, protecting endometrium from unopposed estrogen without regulating cycles or improving androgens as effectively as combination pills.

Medications for Hirsutism and Acne

Spironolactone:

An aldosterone antagonist with anti-androgen properties, highly effective for hirsutism and acne:

• Blocks androgen receptors in skin and hair follicles
• Reduces testosterone production
• Improves hirsutism in 60-70% of women (requires 6-12 months for full effect)
• Improves acne more rapidly (2-3 months)

Dose: 50-200 mg daily. Side effects: Irregular periods (if not on contraceptive), increased urination, low blood pressure, hyperkalemia (elevated potassium, requiring monitoring). Contraindicated in pregnancy (causes birth defects), so must be used with reliable contraception.

Often combined with oral contraceptives for additive anti-androgen effects.

Eflornithine (Vaniqa):

Topical cream slowing facial hair growth. Applied twice daily to face. Effective in 30-50% of women, reduces hair growth but doesn’t eliminate existing hair (still requires hair removal methods). Expensive, requires continuous use.

Mechanical Hair Removal:

Shaving, plucking, waxing, threading—provide immediate results but require frequent maintenance. Electrolysis and laser hair removal provide longer-lasting results by destroying hair follicles. Multiple sessions (6-12) required, works best on dark coarse hair, expensive but may be worthwhile for severe hirsutism.

Topical Retinoids:

Tretinoin, adapalene for acne. First-line topical acne treatment, often combined with benzoyl peroxide or antibiotics.

Isotretinoin (Accutane):

Highly effective for severe, resistant acne. Requires strict contraception due to severe birth defects. Reserved for severe cases unresponsive to other treatments.

Fertility Treatment

For women with PCOS desiring pregnancy:

Lifestyle Optimization:

Weight loss if overweight/obese should be attempted first—many women conceive naturally after 5-10% weight loss without fertility medications.

Ovulation Induction:

Clomiphene (Clomid):

First-line ovulation induction medication. Blocks estrogen receptors in hypothalamus, increasing FSH release, stimulating follicle development and ovulation. 60-80% of women ovulate with clomiphene, 30-40% conceive within 6 cycles. Typical starting dose 50 mg days 3-7 or 5-9 of cycle, increased to 100-150 mg if no ovulation.

Letrozole (Femara):

An aromatase inhibitor (cancer drug repurposed for fertility). Recent studies suggest higher ovulation and pregnancy rates than clomiphene in women with PCOS. May be preferred first-line now, though clomiphene more widely used historically.

Gonadotropin Injections:

If clomiphene/letrozole fail, injectable FSH directly stimulates follicle development. More effective but expensive, requires frequent monitoring (ultrasounds, blood tests), carries risk of multiple pregnancy and ovarian hyperstimulation syndrome.

Metformin:

May improve spontaneous ovulation and enhances response to clomiphene/letrozole, though less effective as sole fertility treatment.

In Vitro Fertilization (IVF):

Reserved for women who don’t respond to ovulation induction, have other infertility factors (tubal disease, male factor), or after prolonged unsuccessful attempts. Women with PCOS respond well to IVF but require careful monitoring to prevent ovarian hyperstimulation.

Ovarian Drilling:

Laparoscopic surgery making small holes in ovaries with laser or electrocautery, reducing androgen production and sometimes restoring ovulation. Reserved for clomiphene-resistant PCOS, less commonly used now with effective medical alternatives.

Long-Term Health Monitoring

Women with PCOS require lifelong monitoring and preventive care:

Annual:

• Fasting glucose or HbA1c (diabetes screening)
• Lipid panel
• Blood pressure
• Weight, BMI, waist circumference
• Assessment for symptoms of depression/anxiety

Every 2-3 Years:

• Oral glucose tolerance test (more sensitive than fasting glucose for detecting prediabetes)

As Needed:

• Liver function tests if obesity, metabolic syndrome, or symptoms suggesting NAFLD
• Sleep apnea screening if symptoms (snoring, daytime sleepiness, witnessed apneas)

After Age 50 (Post-Menopause):

• Cardiovascular risk assessment intensifies
• Continued metabolic monitoring
• Note: PCOS doesn’t “go away” after menopause—metabolic risks persist and may worsen

---

Early Detection and Prevention of PCOS

While PCOS cannot be prevented in genetically susceptible individuals, early detection enables interventions that prevent symptom progression, preserve fertility, and reduce long-term complications. Understanding risk factors and recognizing early signs are crucial for timely diagnosis.

Who Is at Risk for PCOS?

Family History:

The strongest risk factor. If your mother or sister has PCOS, your risk increases 20-40%. Some families have multiple affected members across generations. PCOS also clusters with type 2 diabetes—women with family history of diabetes have increased PCOS risk.

Early Menstrual Irregularities:

Girls whose periods never regularize after menarche (remaining irregular 2-3 years post-menarche) may have PCOS. While some irregularity is normal in the first 1-2 years after first period, persistent irregularity warrants evaluation. Early recognition in adolescence enables lifestyle interventions that may prevent metabolic progression.

Early Weight Gain or Obesity:

Particularly if weight gain occurs around puberty and is difficult to control despite reasonable diet and activity. Obesity worsens PCOS expression, though remember that 30-40% of women with PCOS are normal weight.

Type 2 Diabetes or Prediabetes:

Women diagnosed with prediabetes or type 2 diabetes at young ages (<40) should be evaluated for PCOS—approximately 50% of young women with type 2 diabetes have PCOS.

Premature Adrenarche:

Early development of pubic hair (before age 8), often accompanied by body odor and acne, suggests early androgen exposure and increased PCOS risk.

Low Birth Weight:

Some studies suggest women born with low birth weight have increased PCOS risk, possibly due to fetal programming of insulin resistance.

Ethnicity:

Higher prevalence and more severe metabolic features in South Asian, Middle Eastern, and Hispanic women. These populations warrant particularly vigilant screening.

Early Warning Signs: When to Suspect PCOS

In Adolescence:

Irregular Periods Beyond 2-3 Years Post-Menarche:

If menstrual cycles haven’t regularized by 2-3 years after first period (still occurring <every 35 days or >every 35 days, unpredictable), PCOS evaluation is warranted. Don’t dismiss as “normal teenage irregularity” if persistent.

Severe, Persistent Acne:

Particularly if unresponsive to typical acne treatments, affecting jawline and back, or persisting into late teens/early twenties.

Excess Hair Growth:

Developing coarse, dark facial hair (upper lip, chin) during teenage years, particularly if rapid or progressive. Some facial hair can be normal, but PCOS hirsutism is typically more extensive.

Unexplained Weight Gain:

Significant weight gain during adolescence without clear dietary cause, particularly if abdominal distribution.

Acanthosis Nigricans:

Dark, velvety skin patches on neck, armpits, or groin appearing during puberty—highly suggestive of insulin resistance.

In Adults:

Difficulty Conceiving:

After 6-12 months of unprotected intercourse without pregnancy, particularly if periods are irregular. PCOS is the most common cause of anovulatory infertility.

New-Onset Irregular Periods:

If previously regular periods become irregular in twenties or thirties without pregnancy, perimenopause, or other explanation.

Progressive Hirsutism or Acne:

Worsening facial hair or adult acne developing or worsening in twenties-thirties without clear cause.

Weight Gain Resistant to Diet and Exercise:

Progressive weight gain, particularly abdominal, despite efforts to maintain weight. Difficulty losing weight that seems disproportionate to caloric intake.

Early Metabolic Warning Signs:

Prediabetes, type 2 diabetes, high triglycerides, or low HDL cholesterol diagnosed at young ages (<40).

The Importance of Laboratory Testing for Early Detection

Why Clinical Suspicion Isn’t Enough:

PCOS symptoms overlap with many conditions, and some women have PCOS with subtle symptoms. Laboratory testing is essential for confirming diagnosis, excluding mimicking conditions, and assessing metabolic status.

Essential Initial Testing When PCOS Is Suspected:

Hormonal Evaluation:

• Total testosterone and/or free testosterone: Identifies biochemical hyperandrogenism. Some women have clinical signs (hirsutism) without elevated testosterone, while others have elevated testosterone without visible signs.
• DHEA-S: Rules out adrenal androgen excess.
• LH and FSH: Elevated LH-to-FSH ratio supports PCOS diagnosis (though not required).
• TSH: Excludes thyroid disorders mimicking PCOS.
• Prolactin: Excludes hyperprolactinemia causing similar symptoms.
• 17-hydroxyprogesterone (if appropriate): Screens for non-classic congenital adrenal hyperplasia.

Metabolic Evaluation:

• Fasting glucose and insulin: Assesses insulin resistance and diabetes risk. Fasting insulin >15-20 μIU/mL suggests significant insulin resistance.
• HbA1c: Diabetes screening.
• Oral glucose tolerance test (OGTT): Gold standard for detecting impaired glucose tolerance (prediabetes), present in 30-40% of women with PCOS. Should be performed at diagnosis and repeated every 2-3 years.
• Lipid panel: Dyslipidemia common even in young, lean women with PCOS.

Optional:

• SHBG: Low SHBG indicates insulin resistance and increases free testosterone. Very low SHBG suggests severe insulin resistance.

Pelvic Ultrasound (If Appropriate):

Transvaginal ultrasound evaluates ovarian morphology (polycystic ovaries). However, ultrasound is NOT recommended as primary diagnostic test in adolescents (polycystic ovaries very common in normal adolescence) and isn’t required for PCOS diagnosis if other criteria are met.

When to Get Tested:

Routine Screening Not Recommended:

Unlike thyroid or cholesterol, universal screening of asymptomatic women without risk factors isn’t recommended due to cost and lack of evidence for benefit.

Targeted Testing Recommended For:

• Women with irregular periods (>35 days between cycles, <8 periods/year)
• Hirsutism or severe acne
• Difficulty conceiving after 6-12 months
• Family history of PCOS (particularly if also have any symptoms)
• Metabolic abnormalities at young age (prediabetes, diabetes <40, dyslipidemia)
• Unexplained weight gain or difficulty losing weight
• Signs of insulin resistance (acanthosis nigricans)

Adolescent Testing:

Consider PCOS evaluation in adolescent girls 2-3 years post-menarche with:

• Persistent irregular cycles
• Severe acne unresponsive to treatment
• Hirsutism
• Significant weight gain with acanthosis nigricans

The Value of Early Detection:

In Adolescence:

Early PCOS diagnosis enables lifestyle interventions during critical developmental period before metabolic abnormalities become entrenched. Lifestyle changes in adolescence may prevent progression to severe insulin resistance, obesity, and diabetes. Additionally, understanding PCOS explains troubling symptoms (irregular periods, acne, weight), reduces anxiety, and validates experiences.

In Reproductive Years:

Early diagnosis before fertility is desired allows proactive management:

• Lifestyle interventions improve insulin resistance and preserve fertility
• Regular menstrual cycles (through contraceptives or lifestyle) protect endometrium from unopposed estrogen
• Metabolic monitoring catches prediabetes/diabetes early when intervention is most effective
• When pregnancy is desired, fertility treatments are available and highly effective

Preventing Long-Term Complications:

The 50% lifetime diabetes risk in PCOS is not inevitable. Lifestyle interventions and metformin prevent or delay diabetes progression in women with prediabetes. Early cardiovascular risk factor management (addressing dyslipidemia, hypertension) reduces cardiovascular disease risk. Regular endometrial protection (through regular periods) prevents endometrial cancer.

Cost-Effectiveness:

Early PCOS detection and management prevents expensive complications—diabetes, cardiovascular disease, costly fertility treatments when unmanaged PCOS causes severe anovulation. The cost of hormonal testing and metabolic screening is far less than treating advanced complications.

What Can Be Prevented or Modified

Primary Prevention (Preventing PCOS Development):

PCOS cannot be prevented in genetically susceptible individuals. However, maintaining healthy weight, balanced diet, and regular exercise may delay onset or reduce severity in at-risk women (those with family history).

Secondary Prevention (Early Detection and Intervention):

Since primary prevention is impossible, secondary prevention through early detection and intervention is crucial:

Lifestyle Intervention:

Early, aggressive lifestyle modification in women newly diagnosed with PCOS, particularly adolescents and young adults, may prevent metabolic progression. Women who maintain normal weight, healthy diet, and regular exercise have milder PCOS symptoms and lower complication rates than those who develop obesity.

Metformin for Diabetes Prevention:

Women with PCOS and prediabetes should be offered metformin, which reduces diabetes progression by 40-50%. This preventive use is particularly important given the high diabetes risk in PCOS.

Regular Menstrual Cycles:

Ensuring regular periods (whether through lifestyle, contraceptives, or progestin) prevents endometrial hyperplasia and cancer from chronic anovulation.

Fertility Preservation:

Early diagnosis allows proactive fertility planning. Women aware of PCOS can plan pregnancies earlier if desired (fertility declines with age in PCOS just as in other women) and know that effective fertility treatments exist.

Tertiary Prevention (Preventing Complications in Established PCOS):

Once PCOS is diagnosed:

Prevent Diabetes:

Through weight management, diet, exercise, metformin, and regular screening (catching prediabetes early).

Prevent Cardiovascular Disease:

Through managing cholesterol, blood pressure, quitting smoking, maintaining healthy weight, and addressing inflammation.

Prevent Endometrial Cancer:

Through regular menstrual cycles (contraceptives or progestin therapy) ensuring endometrial shedding at least every 3 months.

Preserve Fertility:

Through weight management, treating insulin resistance, and timely fertility treatment when pregnancy is desired.

Address Mental Health:

Screening and treating depression and anxiety improves quality of life and may improve metabolic outcomes through better self-care.

The overarching message: While you cannot prevent PCOS, early detection and comprehensive management prevent most serious complications and enable women with PCOS to live healthy, fulfilling lives.

---

Living With PCOS

PCOS is a chronic condition requiring lifelong management, but with proper treatment and self-care, most women with PCOS thrive.

Comprehensive Care

PCOS management requires coordinated care, ideally involving:

• Primary care physician or internist: Overall health management, metabolic monitoring
• Gynecologist or reproductive endocrinologist: Hormonal management, fertility treatment
• Endocrinologist: Particularly if diabetes or complex metabolic issues
• Registered dietitian: Individualized nutrition counseling
• Mental health professional: Addressing psychological impact
• Dermatologist: Severe acne or hirsutism management

Self-Advocacy

Many women with PCOS experience dismissive healthcare—”just lose weight,” “your periods don’t matter,” “it’s just cosmetic.” Women often must advocate for appropriate evaluation and comprehensive management. Seeking providers knowledgeable about PCOS, ideally reproductive endocrinologists or endocrinologists specializing in PCOS, improves care quality.

Realistic Expectations

Weight Management:

Accept that weight loss is harder with PCOS but possible. Celebrate non-scale victories—improved menstrual regularity, better labs, increased energy—not just pounds lost. Sustainable lifestyle changes matter more than rapid weight loss.

Hirsutism Management:

Understand that medications prevent new growth but don’t eliminate existing hair—cosmetic hair removal remains necessary. Improvement takes 6-12 months. Finding a manageable hair removal routine and accepting some hair growth reduces stress.

Fertility:

PCOS causes infertility but is highly treatable—ovulation induction has 60-80% pregnancy rates. Many women with PCOS conceive naturally after lifestyle interventions. However, being proactive and seeking fertility treatment sooner rather than waiting years reduces frustration and improves outcomes.

Emotional and Psychological Support

Support Groups:

Online and in-person PCOS support groups provide community, shared experiences, and practical advice from others navigating similar challenges. Many women report feeling less isolated after connecting with others with PCOS.

Mental Health Treatment:

Don’t hesitate to seek counseling or psychiatric treatment for depression or anxiety. PCOS increases mental health risks—getting help is part of comprehensive PCOS management, not weakness.

Body Acceptance:

PCOS features—weight gain, hirsutism, acne, hair loss—profoundly affect body image. Working toward acceptance of your body while pursuing reasonable management of symptoms improves quality of life more than striving for unattainable “perfection.”

Pregnancy and Postpartum

Pregnancy Planning:

Optimize metabolic health before conception—achieve best possible weight, manage blood sugar. If on metformin, discuss continuation through pregnancy (increasingly recommended). Consider preconception genetic counseling if planning fertility treatment.

During Pregnancy:

PCOS increases gestational diabetes risk—ensure early glucose screening (often first trimester, repeated at standard 24-28 weeks). Monitor for preeclampsia. Close obstetric care manages risks.

Postpartum:

PCOS doesn’t disappear after pregnancy. Contraception is important if not desiring immediate subsequent pregnancy (fertility returns postpartum despite previous infertility). Breastfeeding may improve insulin sensitivity. Return to PCOS management postpartum.

Perimenopause and Beyond

PCOS doesn’t resolve at menopause. Metabolic risks continue and potentially worsen. Ongoing monitoring for diabetes, cardiovascular disease, and metabolic syndrome remains crucial. Some symptoms improve (hirsutism may stabilize, menstrual irregularity becomes irrelevant) while others persist (weight, metabolic issues).

---

Polycystic ovary syndrome is a complex, chronic condition affecting reproductive, metabolic, and psychological health. Early diagnosis through clinical evaluation and laboratory testing enables comprehensive management with lifestyle interventions, targeted medications, and regular monitoring, improving symptoms, restoring fertility, and preventing long-term complications. Most women with PCOS, when appropriately diagnosed and managed, live healthy, fulfilling lives.